Aurobindo Pharma shares in focus after European Commission nod for cancer drug Dazublys
Aurobindo Pharma's subsidiary, CuraTeQ Biologics, secured European Commission approval for its trastuzumab biosimilar, Dazublys, indicated for HER2-positive cancers. This marks CuraTeQ's third EMA-approved biosimilar in 2025, reinforcing Aurobindo's focus on biosimilars with plans for 10 launches by 2030. Analysts predict a potential 20% upside for Aurobindo Pharma shares, with a consensus 'Buy' rating.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
4 hours ago
- NDTV
Where Do Trade Talks Stand In Rush To Avert Higher US Tariffs?
As a Wednesday deadline approaches for steeper US tariffs to hit dozens of economies ranging from the EU to India, trade negotiations with President Donald Trump's administration are coming down to the wire. The levies taking effect July 9 were announced in April, with the White House citing a lack of "reciprocity" in trade relations. But they were swiftly halted, allowing room for talks. Days before their reimposition, where do things stand? EU: 'Ready' for deal The European Union said it is "ready for a deal" with Washington, with the bloc's trade chief meeting his US counterparts Thursday. European Commission president Ursula von der Leyen said the EU was targeting an "agreement in principle" when it came to the July 9 cutoff. With no deal, the US tariff on EU goods doubles from the "baseline" of 10 percent to 20 percent -- with Trump previously threatening a 50 percent level. Vietnam: A pact with uncertainties Washington and Hanoi unveiled a trade pact Wednesday with much fanfare and few details, but it allowed Vietnam to avoid Trump's initial 46 percent tariff. Under the agreement, Vietnamese goods face a minimum 20 percent tariff while products made elsewhere face a 40 percent levy -- a clause to restrict "transshipping" by Chinese groups. But there remain questions on how the higher levy would apply to products using foreign parts. There is also a risk that Beijing will adopt retaliatory measures, analysts warned. Japan: Rice, autos at stake Despite being a close US ally and major source of foreign investment, Japan might not escape Trump's tariff hike. Tokyo's trade envoy Ryosei Akazawa has made numerous trips to Washington through the end of June. But Trump recently criticized what he described as Japan's reluctance to open up further to US rice and auto exports. "I'm not sure we're going to make a deal," Trump said, adding that the country could pay a tariff of "30 percent, 35 percent, or whatever the number is that we determine." India: A good position Indian manufacturers and exporters want to believe they can avoid a 26 percent tariff. Negotiations between both countries have been going well for weeks, and Trump himself suggested at the end of June that a "very big" agreement was imminent. Ajay Sahai, director general of the Federation of Indian Export Organisations, said the feedback he received "suggests positive developments." But he maintained that the situation was fluid. Finance Minister Nirmala Sitharaman has stressed that agriculture and dairy products remain "very big red lines." South Korea: Muted optimism Seoul, which is already reeling from US tariffs on steel and autos, wants to avert a sweeping 25 percent levy on its other exports. Cooperation in shipbuilding could be a bargaining chip, but "at this stage, both sides still haven't clearly defined what exactly they want," said new President Lee Jae Myung on Thursday. "I can't say with confidence that we'll be able to wrap everything up by July 8," he added. Indonesia, Thailand, Taiwan in the wings Other Asian economies including Indonesia, Thailand and Cambodia, which faces a 49 percent tariff, wait with bated breath. Indonesia has indicated willingness to boost energy, agriculture and merchandise imports from the United States. Bangladesh meanwhile is proposing to buy Boeing planes and step up imports of US agriculture products. Taiwan, for whom Washington is a vital security partner, faces a 32 percent duty without a pact. Although both sides have faced bumps along the way, Taiwanese Vice President Hsiao Bi-khim said "negotiators from both sides are working diligently" to find a path forward. Switzerland: Hope for delay Switzerland's government said Washington has acknowledged it was acting in good faith, and assumes its tariff level will remain at 10 percent on July 9 while negotiations continue. But without a decision by the president as of the end of June, Switzerland did not rule out that levies could still rise to a promised 31 percent.
NDTV
17 hours ago
- NDTV
Will The EU Delay Enforcing Its AI Act?
With less than a month to go before parts of the European Union's AI Act come into force, companies are calling for a pause in the provisions and getting support from some politicians. Groups representing big U.S. tech companies such as Google owner Alphabet and Facebook owner Meta, and European companies such as Mistral and ASML have urged the European Commission to delay the AI Act by years. What Is The August 2 Deadline? Under the landmark act that was passed a year earlier after intense debate between EU countries, its provisions would come into effect in a staggered manner over several years. Some important provisions, including rules for general purpose AI (GPAI) models, are due to apply on August 2. GPAI, which includes foundation models like those made by Google, Mistral and OpenAI, will be subject to transparency requirements such as drawing up technical documentation, complying with EU copyright law and providing detailed summaries about the content used for algorithm training. The companies will also need to test for bias, toxicity, and robustness before launching. AI models classed as posing a systemic risk and high-impact GPAI will have to conduct model evaluations, assess and mitigate risks, conduct adversarial testing, report to the European Commission on serious incidents and provide information on their energy efficiency. Why Do Companies Want A Pause? For AI companies, the enforcement of the act means additional costs for compliance. And for ones that make AI models, the requirements are tougher. But companies are also unsure how to comply with the rules as there are no guidelines yet. The AI Code of Practice, a guidance document to help AI developers to comply with the act, missed its publication date of May 2. "To address the uncertainty this situation is creating, we urge the Commission to propose a two-year 'clock-stop' on the AI Act before key obligations enter into force," said an open letter published on Thursday by a group of 45 European companies. It also called for simplification of the new rules. Another concern is that the act may stifle innovation, particularly in Europe where companies have smaller compliance teams than their U.S. counterparts. Will It Be Postponed? The European Commission has not yet commented on whether it will postpone the enforcement of the new rules in August. However, EU tech chief Henna Virkkunen promised on Wednesday to publish the AI Code of Practice before next month. Some political leaders, such as Swedish Prime Minister Ulf Kristersson, have also called the AI rules "confusing" and asked the EU to pause the act. "A bold 'stop-the-clock' intervention is urgently needed to give AI developers and deployers legal certainty, as long as necessary standards remain unavailable or delayed," tech lobbying group CCIA Europe said. The European Commission did not respond immediately to requests for comment.
Indian Express
18 hours ago
- Indian Express
Trump's ‘big, beautiful' tax bill passes final vote, advances to President's desk
After days of Republican infighting and dramatic 11th-hour lobbying, the House of Representatives on Thursday morning passed President Donald Trump's multi-trillion-dollar tax and spending bill, clearing the final hurdle just in time for Trump's self-imposed July Fourth deadline. The vote followed intense pressure from the White House and House Speaker Mike Johnson, who managed to flip key GOP holdouts. The bill, projected to add nearly $1 trillion more to the deficit than the House's earlier version, had drawn backlash from Republican fiscal hawks. Despite the concerns, the House greenlit the Senate-approved version, setting in motion what Trump has called the 'One Big, Beautiful Bill' — a sprawling policy package that promises deep tax cuts, massive national security spending, and historic reductions to the federal safety net. 'I will take my sweet time,' said House Minority Leader Hakeem Jeffries, who used his 'magic minute' rule to speak for hours and underscore Democratic opposition. The bill now heads to the president's desk for signing.
